Home
News
Create
Screeners
Insights
GKB Ophthalmics
52.
25
+0.70
(+1.36%)
Market Cap
₹26.35 Cr
PE Ratio
-5.38
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.36%
1M
+3.57%
6M
-29.71%
1Y
-42.04%
5Y
-16.20%
View Company Insights
Latest news about GKB Ophthalmics
GKB Ophthalmics Ltd Reports Insider Trading Disclosure Under SEBI Regulations
Dec 30, 2025
GKB Ophthalmics Ltd filed an insider trading disclosure with BSE regarding the purchase of 3,607 equity shares worth ₹2,14,003.07 by promoter group entity Krishna Gopal Gupta & Sons (HUF) between November 20-December 10, 2025. The disclosure was made under SEBI regulations as a corporate governance measure, despite the transaction being below prescribed thresholds.
GKB Ophthalmics' Subsidiary GSV Ophthalmics Approves Voluntary Liquidation
Nov 20, 2025
GKB Ophthalmics Shareholders Approve Voluntary Winding Up of Material Subsidiary GSV Ophthalmics
Nov 03, 2025
GKB Ophthalmics Reduces Production by 50% Amid Market Challenges, Wins Export Excellence Award
Oct 11, 2025
GKB Ophthalmics Initiates Voluntary Liquidation of Material Subsidiary GSV Ophthalmics
Sep 22, 2025
More news about GKB Ophthalmics
12
Sept 25
GKB Ophthalmics Faces Rs 8.82 Crore Recovery Order Amid Ongoing Labour Dispute
GKB Ophthalmics Limited has been directed by the Labour Commissioner to pay Rs 8.82 crore in a labour dispute dating back to 2009. The order, received on September 12, 2023, relates to an award passed by the Industrial Tribunal in 2021. The company plans to challenge this order in the High Court of Bombay at Goa, arguing that crucial factors were not considered in the original award. GKB Ophthalmics does not admit liability and is already contesting the original award through a writ petition.
25
Aug 25
Ace Investor Vijay Kedia Weighs In on GKB Ophthalmics Shareholder Controversy
Ace investor Vijay Kedia has commented on a recent incident involving GKB Ophthalmics Ltd and a shareholder, Abhishek Kalra. During the company's virtual AGM, Kalra criticized the management for poor stock performance and governance issues, demanding the Managing Director's resignation. Kedia condemned the harsh language used but supported the underlying message, emphasizing the importance of respecting shareholder money and holding incompetent managements accountable. The incident has sparked discussions about shareholder activism and corporate governance in India.
23
Aug 25
GKB Ophthalmics Faces Shareholder Criticism at Virtual AGM
GKB Ophthalmics Ltd held its 43rd Annual General Meeting (AGM) virtually on August 21, 2025. The meeting was marked by controversy when shareholder Abhishek Kalra, owning one share, verbally attacked the company's management. Kalra criticized Managing Director Krishna Gopal Gupta's performance and demanded his resignation within 10 days. The confrontation occurred against a backdrop of weak stock performance, with shares declining 32.27% over the past year and 18.38% year-to-date. Despite the incident, the AGM proceeded with its agenda, passing several resolutions including financial statement adoption, director re-appointment, and approval of related party transactions. The meeting saw participation from 55 shareholders, with all resolutions passed by the requisite majority.
19
Aug 25
Thakkers Group Reports 85% Revenue Surge in Q1, Net Profit Jumps 68%
Thakkers Group Limited, a real estate developer, reported strong Q1 results with total income rising 85.3% to Rs 791.88 lakhs and net profit increasing 68% to Rs 261.20 lakhs year-over-year. Earnings per share improved to Rs 16.50 from Rs 9.82. The company's reserves grew to Rs 5815.20 lakhs, while paid-up equity share capital remained at Rs 158.33 lakhs. However, revenue saw a slight sequential decline from the previous quarter.
GKB Ophthalmics
52.
25
+
0.
70
(+
1.
36
%)
1 Year Returns:
-42.04%
Industry Peers
Poly Medicure
1,681.60
(-
1.
86
%)
Laxmi Dental
241.55
(-
0.
98
%)
Tarsons Products
220.01
(+
1.
48
%)
Vasa Denticity
580.00
(0.0%)
Osel Devices
501.25
(-
0.
15
%)
Fabtech Technologies
188.90
(-
0.
08
%)
Prevest Denpro
463.00
(-
1.
49
%)
Aprameya Engineering
261.05
(+
0.
79
%)
Hemant Surgical Industries
292.00
(-
3.
99
%)
Nureca
291.95
(+
2.
78
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation